However in the post hoc analysis, we showed that there was a significant trend toward worse outcome in those with high OPR suggesting that cilostazol may have some beneficial effects in higher-risk populations.
← all excerpts
The 'Harmonizing Optimal Strategy for Treatment of coronary artery stenosis - sAfety & effectiveneSS of drug-elUting stents & antiplatelet REgimen' (HOST-ASSURE) trial: study protocol for a randomized controlled trial.
1
—
—